{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:29:08Z","timestamp":1781191748281,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11845-022-02979-y","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:03:06Z","timestamp":1648062186000},"page":"149-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retinal ultrastructural, electrophysiological, and microvascular morphological outcomes in diabetic macular edema treated with intravitreal bevacizumab"],"prefix":"10.1007","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-409X","authenticated-orcid":false,"given":"Furkan Fatih","family":"Gulyesil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-2205","authenticated-orcid":false,"given":"Sibel","family":"Inan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7656-3155","authenticated-orcid":false,"given":"Hamidu Hamisi","family":"Gobeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-9961","authenticated-orcid":false,"given":"Mehmet Cem","family":"Sabaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3408-6167","authenticated-orcid":false,"given":"Anar","family":"Alizada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"2979_CR1","doi-asserted-by":"publisher","first-page":"2156273","DOI":"10.1155\/2016\/2156273","volume":"2016","author":"P Romero-Aroca","year":"2016","unstructured":"Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A et al (2016) Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res 2016:2156273. https:\/\/doi.org\/10.1155\/2016\/2156273","journal-title":"J Diabetes Res"},{"key":"2979_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/dc15-2171","volume":"39","author":"JL Leasher","year":"2016","unstructured":"Leasher JL, Bourne RR, Flaxman SR et al (2016) Vision loss expert group of the global burden of disease study. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 39:1643\u20131649. https:\/\/doi.org\/10.2337\/dc15-2171","journal-title":"Diabetes Care"},{"key":"2979_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IIO.0b013e31819fd164","volume":"49","author":"A Singh","year":"2009","unstructured":"Singh A, Stewart JM (2009) Pathophysiology of diabetic macular edema. Int Ophthalmol Clin 49:1\u201311. https:\/\/doi.org\/10.1097\/IIO.0b013e31819fd164","journal-title":"Int Ophthalmol Clin"},{"key":"2979_CR4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0161-6420(13)38011-7","volume":"98","author":"Early photocoagulation for diabetic retinopathy","year":"1991","unstructured":"Early photocoagulation for diabetic retinopathy (1991) ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98:766\u2013785","journal-title":"Ophthalmology"},{"key":"2979_CR5","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1167\/iovs.02-0807","volume":"44","author":"S Ishida","year":"2003","unstructured":"Ishida S, Usui T, Yamashiro K et al (2003) VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44:2155\u20132162. https:\/\/doi.org\/10.1167\/iovs.02-0807","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2979_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124\u2013136. https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3","journal-title":"Lancet"},{"key":"2979_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S2213-8587(16)30052-3","volume":"5","author":"GS Tan","year":"2017","unstructured":"Tan GS, Cheung N, Sim\u00f3 R et al (2017) Diabetic macular edema Lancet Diabetes Endocrinol 5:143\u2013155. https:\/\/doi.org\/10.1016\/S2213-8587(16)30052-3","journal-title":"Diabetic macular edema Lancet Diabetes Endocrinol"},{"key":"2979_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR et al (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372:1193\u20131203. https:\/\/doi.org\/10.1056\/NEJMoa1414264","journal-title":"N Engl J Med"},{"key":"2979_CR9","doi-asserted-by":"publisher","first-page":"E2395","DOI":"10.1073\/pnas.1500185112","volume":"112","author":"Y Jia","year":"2015","unstructured":"Jia Y, Bailey ST, Hwang TS et al (2015) Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A 112:E2395-2402. https:\/\/doi.org\/10.1073\/pnas.1500185112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2979_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.16-20579","volume":"58","author":"K Ghasemi Falavarjani","year":"2017","unstructured":"Ghasemi Falavarjani K, Iafe NA, Hubschman JP et al (2017) Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion. Invest Ophthalmol Vis Sci 58:30\u201334. https:\/\/doi.org\/10.1167\/iovs.16-20579","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2979_CR11","doi-asserted-by":"publisher","unstructured":"Nesper PL, Roberts PK, Onishi AC et al (2017) Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 58:BIO307-BIO315.\u00a0https:\/\/doi.org\/10.1167\/iovs.17-21787","DOI":"10.1167\/iovs.17-21787"},{"key":"2979_CR12","doi-asserted-by":"publisher","unstructured":"Dimitrova G, Chihara E, Takahashi H et al (2017) Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy. Invest Ophthalmol Vis Sci 58:190\u2013196. https:\/\/doi.org\/10.1167\/iovs.16-20531","DOI":"10.1167\/iovs.16-20531"},{"key":"2979_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/08820538.2017.1375125","volume":"33","author":"A Molina-Mart\u00edn","year":"2018","unstructured":"Molina-Mart\u00edn A, P\u00e9rez-Cambrod\u00ed RJ, Pi\u00f1ero DP (2018) Current clinical application of microperimetry: a review. Semin Ophthalmol 33:620\u2013628. https:\/\/doi.org\/10.1080\/08820538.2017.1375125","journal-title":"Semin Ophthalmol"},{"key":"2979_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/IAE.0b013e31817d5d1c","volume":"28","author":"P Grenga","year":"2008","unstructured":"Grenga P, Lupo S, Domanico D et al (2008) Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study. Retina 28:1270\u20131275. https:\/\/doi.org\/10.1097\/IAE.0b013e31817d5d1c","journal-title":"Retina"},{"key":"2979_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000081777","volume":"219","author":"T Kube","year":"2005","unstructured":"Kube T, Schmidt S, Toonen F et al (2005) Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with a scanning laser ophthalmoscope. Ophthalmologica 219:16\u201320. https:\/\/doi.org\/10.1159\/000081777","journal-title":"Ophthalmologica"},{"key":"2979_CR16","doi-asserted-by":"publisher","unstructured":"Yau JW, Rogers SL, Kawasaki R et al (2012) Meta-analysis for eye disease (META-EYE) study group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556\u2013564. https:\/\/doi.org\/10.2337\/dc11-1909\u00a0(Epub 2012 Feb 1)","DOI":"10.2337\/dc11-1909"},{"key":"2979_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3389\/fpls.2016.01156","volume":"7","author":"L Chen","year":"2016","unstructured":"Chen L, Yang X, Luo D et al (2016) Efficient production of a bioactive bevacizumab monoclonal antibody using the 2A self-cleavage peptide in transgenic rice callus. Front Plant Sci 7:1156. https:\/\/doi.org\/10.3389\/fpls.2016.01156","journal-title":"Front Plant Sci"},{"key":"2979_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10456-004-8272-2","volume":"7","author":"Y Wang","year":"2004","unstructured":"Wang Y, Fei D, Vanderlaan M et al (2004) Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro. Angiogenesis 7:335\u2013345. https:\/\/doi.org\/10.1007\/s10456-004-8272-2","journal-title":"Angiogenesis"},{"key":"2979_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/IAE.0b013e31815ec261","volume":"27","author":"M Soheilian","year":"2007","unstructured":"Soheilian M, Ramezani A, Bijanzadeh B et al (2007) Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina 27:1187\u20131195. https:\/\/doi.org\/10.1097\/IAE.0b013e31815ec261","journal-title":"Retina"},{"key":"2979_CR20","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ophtha.2010.03.045","volume":"117","author":"M Michaelides","year":"2010","unstructured":"Michaelides M, Kaines A, Hamilton RD et al (2010) A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 117:1078-1086.e2. https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.045","journal-title":"Ophthalmology"},{"key":"2979_CR21","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1167\/iovs.08-2113","volume":"49","author":"F Forooghian","year":"2008","unstructured":"Forooghian F, Cukras C, Meyerle CB et al (2008) Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 49:4290\u20134296. https:\/\/doi.org\/10.1167\/iovs.08-2113","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2979_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/archopht.125.5.619","volume":"125","author":"RJ Campbell","year":"2007","unstructured":"Campbell RJ, Coupland SG, Buhrmann RR et al (2007) Optimal optical coherence tomography-based measures in the diagnosis of clinically significant macular edema: retinal volume vs foveal thickness. Arch Ophthalmol 125:619\u2013623. https:\/\/doi.org\/10.1001\/archopht.125.5.619","journal-title":"Arch Ophthalmol"},{"key":"2979_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ophtha.2006.06.052","volume":"114","author":"DJ Browning","year":"2007","unstructured":"Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR, Aiello LP et al (2007) Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114:525\u2013536. https:\/\/doi.org\/10.1016\/j.ophtha.2006.06.052","journal-title":"Ophthalmology"},{"key":"2979_CR24","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1097\/IAE.0b013e31820bde7d","volume":"31","author":"M Soheilian","year":"2011","unstructured":"Soheilian M, Ramezani A, Yaseri M et al (2011) Initial macular thickness and response to treatment in diabetic macular edema. Retina 31:1564\u20131573. https:\/\/doi.org\/10.1097\/IAE.0b013e31820bde7d","journal-title":"Retina"},{"key":"2979_CR25","doi-asserted-by":"publisher","unstructured":"Chen YP, Wu AL, Chuang CC et al (2019) Factors influencing clinical outcomes in patients with diabetic macular edema treated with intravitreal ranibizumab: comparison between responder and non-responder cases. Sci Rep 9:10952.\u00a0https:\/\/doi.org\/10.1038\/s41598-019-47241-1","DOI":"10.1038\/s41598-019-47241-1"},{"key":"2979_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2147\/OPTH.S56624","volume":"8","author":"B Mushtaq","year":"2014","unstructured":"Mushtaq B, Crosby NJ, Dimopoulos AT et al (2014) Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema. Clin Ophthalmol 8:807\u2013812. https:\/\/doi.org\/10.2147\/OPTH.S56624","journal-title":"Clin Ophthalmol"},{"key":"2979_CR27","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1167\/iovs.05-1141","volume":"47","author":"S Vujosevic","year":"2006","unstructured":"Vujosevic S, Midena E, Pilotto E et al (2006) Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Invest Ophthalmol Vis Sci 47:3044\u20133051. https:\/\/doi.org\/10.1167\/iovs.05-1141","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2979_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.eye.6702014","volume":"20","author":"K Okada","year":"2006","unstructured":"Okada K, Yamamoto S, Mizunoya S et al (2006) Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye (Lond) 20:805\u2013809. https:\/\/doi.org\/10.1038\/sj.eye.6702014","journal-title":"Eye (Lond)"},{"key":"2979_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4274\/tjo.42.02411","volume":"42","author":"T K\u00fcsbeci","year":"2012","unstructured":"K\u00fcsbeci T, Yavas G, Ubeyt Inan \u00dc (2012) Assessment of macular sensitivity and fixation stability by MP-1 Microperimetry in Diabetic Macular Edema. Turk J Ophthalmol 42:310\u2013315","journal-title":"Turk J Ophthalmol"},{"key":"2979_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1755-3768.2008.01497.x","volume":"88","author":"M Karacorlu","year":"2010","unstructured":"Karacorlu M, Ozdemir H, Senturk F et al (2010) Macular function after intravitreal triamcinolone acetonide injection for diabetic macular edema. Acta Ophthalmol 88:558\u2013563. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01497.x","journal-title":"Acta Ophthalmol"},{"key":"2979_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10792-012-9685-3","volume":"33","author":"R Malagola","year":"2013","unstructured":"Malagola R, Spinucci G, Cofone C et al (2013) Prospective microperimetry and OCT evaluation of efficacy of repeated intravitreal bevacizumab injections for persistent clinically significant diabetic macular edema. Int Ophthalmol 33:261\u2013267. https:\/\/doi.org\/10.1007\/s10792-012-9685-3","journal-title":"Int Ophthalmol"},{"key":"2979_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ajo.2007.07.011","volume":"144","author":"N Unoki","year":"2007","unstructured":"Unoki N, Nishijima K, Sakamoto A et al (2007) Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy. Am J Ophthalmol 144:755\u2013760. https:\/\/doi.org\/10.1016\/j.ajo.2007.07.011","journal-title":"Am J Ophthalmol"},{"key":"2979_CR33","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2147\/OPTH.S220877","volume":"13","author":"M Alonso-Plasencia","year":"2019","unstructured":"Alonso-Plasencia M, Abreu-Gonz\u00e1lez R, G\u00f3mez-Culebras MA (2019) Structure-function correlation using OCT angiography and microperimetry in diabetic retinopathy. Clin Ophthalmol 13:2181\u20132188. https:\/\/doi.org\/10.2147\/OPTH.S220877","journal-title":"Clin Ophthalmol"},{"key":"2979_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40942-019-0176-9","volume":"5","author":"F Pereira","year":"2019","unstructured":"Pereira F, Godoy BR, Maia M et al (2019) Microperimetry and OCT angiography evaluation of patients with ischemic diabetic macular edema treated with monthly intravitreal bevacizumab: a pilot study. Int J Retina Vitreous 5:24. https:\/\/doi.org\/10.1186\/s40942-019-0176-9","journal-title":"Int J Retina Vitreous"},{"key":"2979_CR35","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00417-015-3148-2","volume":"254","author":"FJ Freiberg","year":"2016","unstructured":"Freiberg FJ, Pfau M, Wons J et al (2016) Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 254:1051\u20131058. https:\/\/doi.org\/10.1007\/s00417-015-3148-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2979_CR36","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.ophtha.2016.07.010","volume":"123","author":"J Lee","year":"2016","unstructured":"Lee J, Moon BG, Cho AR et al (2016) Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response. Ophthalmology 123:2368\u20132375. https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.010","journal-title":"Ophthalmology"},{"key":"2979_CR37","doi-asserted-by":"publisher","first-page":"716","DOI":"10.5301\/ejo.5000948","volume":"27","author":"K Sambhav","year":"2017","unstructured":"Sambhav K, Abu-Amero KK, Chalam KV (2017) Deep capillary macular perfusion indices obtained with OCT angiography correlate with degree of nonproliferative diabetic retinopathy. Eur J Ophthalmol 27:716\u2013729. https:\/\/doi.org\/10.5301\/ejo.5000948","journal-title":"Eur J Ophthalmol"},{"key":"2979_CR38","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s10792-018-1013-0","volume":"39","author":"HR AttaAllah","year":"2019","unstructured":"AttaAllah HR, Mohamed AAM, Ali MA (2019) Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography. Int Ophthalmol 39:1845\u20131859. https:\/\/doi.org\/10.1007\/s10792-018-1013-0","journal-title":"Int Ophthalmol"},{"key":"2979_CR39","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s10792-019-01076-x","volume":"39","author":"OA Sorour","year":"2019","unstructured":"Sorour OA, Sabrosa AS, Yasin Alibhai A et al (2019) Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Int Ophthalmol 39:2361\u20132371. https:\/\/doi.org\/10.1007\/s10792-019-01076-x","journal-title":"Int Ophthalmol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-02979-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-022-02979-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-02979-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T06:56:30Z","timestamp":1675234590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-022-02979-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2979"],"URL":"https:\/\/doi.org\/10.1007\/s11845-022-02979-y","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This original study has not been submitted or is not under consideration for publication in another journal. The abstract of the study, however, was presented orally at the 19TH BLACK SEA OPHTHALMOLOGICAL SOCIETY CONGRESS September 24\u201326, 2021 Chisinau, Republic of Moldova, ONLINE.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conference presentation disclosure"}},{"value":"The study procedure abided by the ethical standards of the Helsinki Declaration and obtained full approval from the Institutional Review Boards of the Afyonkarahisar Health Sciences University Ethics Committee. Prior to the study, all participants issued informed written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"My colleagues and I conducted the research and co-authored the manuscript. We have all approved the manuscript for submission and publication in your journal, and I am the corresponding author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"My colleagues and I conducted the research and co-authored the manuscript. We have all approved the manuscript for submission and publication in your journal, and I am the corresponding author.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}